Literature DB >> 12010987

Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells.

Robert E Molestina1, Jon B Klein, Richard D Miller, William H Pierce, Julio A Ramirez, James T Summersgill.   

Abstract

Recent data have shown that the respiratory pathogen Chlamydia pneumoniae expresses an altered gene transcription profile during gamma interferon (IFN-gamma)-induced persistent infection in vitro. In the present study, we examined, by proteomics, expression of C. pneumoniae proteins labeled intracellularly with [(35)S]methionine/cysteine under normal conditions or IFN-gamma-mediated persistence. The identity of differentially expressed proteins during persistent infection was determined by matching spots to those of proteins identified in C. pneumoniae elementary bodies by matrix-assisted laser desorption ionization mass spectrometry. Upon treatment with 50 U of IFN-gamma per ml, a marked upregulation of major outer membrane protein (MOMP), heat shock protein 60 (Hsp-60/GroEL), and proteins with functions in DNA replication (GyrA), transcription (RpoA, PnP), translation (Rrf), glycolysis (PgK, GlgP), and type III secretion (SctN) was observed at 24 h of infection. In contrast, no significant decreases in bacterial protein expression were found in C. pneumoniae-infected cells due to IFN-gamma treatment. Upregulation of C. pneumoniae proteins involved in diverse functions during persistent infection may allow the organism to resist the inhibitory effects of IFN-gamma while retaining basic functions. Future studies should examine the differential expression of chlamydial proteins during the developmental cycle under IFN-gamma pressure to obtain a finer representation of the gene products involved in establishing persistence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010987      PMCID: PMC127979          DOI: 10.1128/IAI.70.6.2976-2981.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

Review 2.  Sample preparation methods for mass spectrometric peptide mapping directly from 2-DE gels.

Authors:  O N Jensen; M Wilm; A Shevchenko; M Mann
Journal:  Methods Mol Biol       Date:  1999

3.  Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism.

Authors:  S J Mehta; R D Miller; J A Ramirez; J T Summersgill
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

4.  Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group.

Authors:  J A Ramirez
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

5.  Comparative genomes of Chlamydia pneumoniae and C. trachomatis.

Authors:  S Kalman; W Mitchell; R Marathe; C Lammel; J Fan; R W Hyman; L Olinger; J Grimwood; R W Davis; R S Stephens
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

6.  Effects of interferon gamma on Chlamydia trachomatis serovar A and L2 protein expression investigated by two-dimensional gel electrophoresis.

Authors:  A C Shaw; G Christiansen; S Birkelund
Journal:  Electrophoresis       Date:  1999 Apr-May       Impact factor: 3.535

Review 7.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

8.  Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells.

Authors:  R E Molestina; D Dean; R D Miller; J A Ramirez; J T Summersgill
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 9.  Chlamydia pneumoniae and cardiovascular disease.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

10.  Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection.

Authors:  J M Penttilä; M Anttila; M Puolakkainen; A Laurila; K Varkila; M Sarvas; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more
  19 in total

1.  Temporal expression of type III secretion genes of Chlamydia pneumoniae.

Authors:  Anatoly Slepenkin; Vladimir Motin; Luis M de la Maza; Ellena M Peterson
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 2.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response.

Authors:  Sanghamitra Mukhopadhyay; Richard D Miller; Erin D Sullivan; Christina Theodoropoulos; Sarah A Mathews; Peter Timms; James T Summersgill
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Tryptophan Codon-Dependent Transcription in Chlamydia pneumoniae during Gamma Interferon-Mediated Tryptophan Limitation.

Authors:  Scot P Ouellette; Kelsey J Rueden; Elizabeth A Rucks
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

Review 5.  Secretome, surfome and immunome: emerging approaches for the discovery of new vaccine candidates against bacterial infections.

Authors:  Pratistha Dwivedi; Syed Imteyaz Alam; Rajesh Singh Tomar
Journal:  World J Microbiol Biotechnol       Date:  2016-07-27       Impact factor: 3.312

6.  Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns.

Authors:  Sebastian Bunk; Hanne Schaffert; Bianca Schmid; Christoph Goletz; Sabine Zeller; Marina Borisova; Florian Kern; Jan Rupp; Corinna Hermann
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

7.  Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Leena Erkkilä; Taina Korhonen; Terttu Tiirola; Aini Bloigu; Pekka Saikku; Maija Leinonen
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

8.  Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins.

Authors:  Anatoly Severin; Elliott Nickbarg; Joseph Wooters; Shakey A Quazi; Yury V Matsuka; Ellen Murphy; Ioannis K Moutsatsos; Robert J Zagursky; Stephen B Olmsted
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

9.  Altered developmental expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis.

Authors:  Jose A Carrasco; Chun Tan; Roger G Rank; Ru-ching Hsia; Patrik M Bavoil
Journal:  Cell Microbiol       Date:  2011-04-26       Impact factor: 3.715

10.  Kinematics of intracellular chlamydiae provide evidence for contact-dependent development.

Authors:  David P Wilson; Judith A Whittum-Hudson; Peter Timms; Patrik M Bavoil
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.